Stocks in Play: BioVaxys Technology Corp
Wednesday, May 7, 2025
10:27 AM EST - BioVaxys Technology Corp : Announces today they have entered into a Research Agreement to collaborate on the development of new cancer therapeutics based on BioVaxys' DPX™ Immune Educating Platform in combination with Sona's Targeted Hyperthermia Therapy™, a photothermal cancer therapy that uses highly targeted infrared light to treat solid tumors. The heat for THT is delivered to tumors using infrared light that is absorbed by Sona's proprietary biocompatible Gold Nanorod technology which elicits a strong immune response. BioVaxys Technology Corp (C.BIOV) shares were unchanged at 0.03.Stocks in Play: BioVaxys Technology Corp, Thu, 08 May 2025 05:57:05 EST
